AstraZeneca, the United Kingdom’s most valuable publicly listed company, has secured the backing of leading shareholder advisory groups for its proposal to achieve a direct listing on the New York
All posts tagged in pharmaceutical sector
2Articles
The United Kingdom stands on the threshold of a radical transformation in obesity treatment, as Eli Lilly prepares to introduce a daily weight-loss pill, Orforglipron, in 2026, once regulatory approval
